Recent Press Releases
December 15, 2025 - Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Nonprofit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US
August 12, 2025 - Orphan Therapeutics Accelerator Launches Orphan Therapies, a Non-Profit Biotech Dedicated to Commercializing Ultra-Rare Disease Treatments
April 23, 2025 - Orphan Therapeutics Accelerator Announces Foundational Partnerships
November 19, 2025 - Alternative Development & Commercialization Strategies for Rare Disease Gene Therapies
October 3, 2025 - How Orphan Therapeutics Accelerator is Optimizing Rare Disease Search and Eval
April 23, 2025 - Orphan Accelerator Creating Non-Profit Model to Commercialize Ultrarare Therapies
March 31, 2025 - Saving Shelved Ultra-Rare Therapies Through Unorthodox Funding
October 15, 2024 - When a Miracle Cure is Left on the Shelf
March 20, 2024 - Non-Profit Biotech Aims to Revive Stalled Ultrarare Therapies
